House Republicans repeal Obamacare, hurdles await in U.S. Senate | | WASHINGTON (Reuters) - The U.S. House of Representatives on Thursday narrowly approved a bill to repeal Obamacare, handing Republican President Donald Trump a victory that could prove short-lived as the healthcare legislation heads into a likely tough battle in the Senate. |
| |
Health insurers focused on 2018 unknowns for Obamacare market | | NEW YORK (Reuters) - While attention is focused on Republicans' fight to pass a bill to repeal Obamacare starting in 2019, health insurers are busy struggling with decisions they need to make now about how to price premiums and what markets they can afford to be in next year. |
| |
Eating pure oats may be okay for celiac sufferers | | (Reuters Health) - People with celiac disease have to avoid most grains, but oats may be an exception that’s safe, according to a recent research review, so long as the oats are uncontaminated by traces of other grains. |
| |
WHO to help bring cheap biosimilar cancer drugs to poor | | LONDON (Reuters) - The World Health Organization (WHO) is to launch a pilot project this year to assess cheap copies of expensive biotech cancer drugs in a bid to make such medicines more widely available in poorer countries. |
| |
J&J ordered to pay $110 million in U.S. talc-powder trial | | (Reuters) - Johnson & Johnson on Thursday was ordered by a Missouri jury to pay over $110 million to a Virginia woman who says she developed ovarian cancer after decades of using of its talc-based products for feminine hygiene. |
| |
Novartis, Roche back French gene therapy start-up Vivet | | (Reuters) - French gene therapy start-up Vivet Therapeutics said on Thursday it had raised 37.5 million euros ($41 million) in an initial financing round, with backing from the venture arms of Swiss drugmakers Novartis and Roche. |
| |
Australia wins landmark WTO tobacco packaging case - Bloomberg | | GENEVA/LONDON (Reuters) - A landmark Australian law on restrictive tobacco packaging has been upheld at the World Trade Organization after a five-year legal battle, Bloomberg news reported on Thursday, citing two people familiar with the situation. |
| |
| | |